Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional Retrospective Study to Describe Early Clinical Experience With Cabozantinib in Patients With Advanced Renal Cell Carcinoma in the United Kingdom (UK)

NCT03696407 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT03696407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03696407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional Retrospective Study to Describe Early Clinical Experience With Cabozantinib in Patients With Advanced Renal Cell Carcinoma in the United Kingdom (UK)
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
December 20, 2018
Completion date
August 1, 2019
Enrollment
108 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

advanced renal cell carcinoma